From: Promoting faster pathways to surgery: a clinical audit of patients with refractory epilepsy
Changes in AEDS prescribed pre- and post-surgical intervention | Â | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | Surgical patients |  | ||||||||||
 |  | a | b | c | d | e | f | g | h | i | j | k | Total |
Lamotrigine | Visit 1 | Â | Â | Â | X | X | Â | X | Â | X | X | Â | 5 |
 | 1st post-op visit |  |  | 0 | 0 | 0 |  | 0 |  | 0 | 0 |  | 6 |
Levetiracetam | Visit 1 | X | X | Â | Â | Â | Â | Â | X | Â | X | X | 5 |
 | 1st post-op visit | 0 | 0 |  |  |  |  |  | 0 |  | 0 | 0 | 5 |
Carbamazepine | Visit 1 | Â | X | Â | X | X | X | Â | Â | Â | X | X | 6 |
 | 1st post-op visit |  |  | 0 | 0 |  | 0 |  |  |  | 0 | 0 | 5 |
Zonisamide | Visit 1 | Â | Â | Â | Â | Â | X | Â | Â | X | Â | Â | 2 |
 | 1st post-op visit | 0 |  |  |  |  | 0 | 0 |  | 0 |  |  | 4 |
Lacosamide | Visit 1 | Â | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | 1 |
 | 1st post-op visit |  | 0 |  |  |  | 0 |  |  |  |  |  | 2 |
Clobazam | Visit 1 | Â | Â | Â | X | Â | Â | Â | Â | X | Â | Â | 2 |
 | 1st post-op visit |  |  |  |  |  |  | 0 |  |  |  |  | 1 |
Oxcarbazepine | Visit 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 0 |
 | 1st post-op visit | 0 |  |  |  |  |  |  |  |  |  |  | 1 |
Clonazepam | Visit 1 | Â | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | 1 |
 | 1st post-op visit |  |  |  |  |  | 0 |  |  |  |  |  | 1 |
Total number of drugs (Visit 1) | 1 | 2 | 0 | 3 | 2 | 4 | 1 | 1 | 3 | 3 | 2 | Â | |
Total number of drugs (1st post-op) | 3 | 2 | 2 | 2 | 1 | 4 | 3 | 1 | 2 | 3 | 2 | Â | |
Number of drugs changed | 2 | 1 | 2 | 1 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | Â |